DOI:10.1038/s41598-020-74022-y 2.Lozic.M, Stambolija.V, Krezic.I, Dugandzic.A, Zivanovic-Posilovic.G, Gojkovic.S, Kovacevic.J, Vrdoljak.L, Mirkovic.I, In relation to NO-System, Stable Pentadecapeptide BPC 157 Counteracts Lidocaine-Induced Adverse Effects in Rats and Depolarisation In Vitro
Any consideration of this therapy must occur under strict, licensed medical supervision
It is supplied in multiple-dose vials and is indicated only for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection, following the instructions of the manufacturer of the drug being given
Focus on nitric oxide and lipoxins
[PubMed: 37385275] Loomba R, Hartman ML, Lawitz EJ, et al